Podcasts about clinical senior lecturer

Send us a textLooking for answers about lubricants, vaginal health, and what's safe to use when pregnant, breastfeeding, or trying to conceive? This episode has you covered.I chat with Dr Raelia Lew about everything from types of lubricants to their role in supporting comfort, intimacy, and pelvic health.In This Episode We Cover:The difference between water, silicone, and oil-based lubricantsWhen and why you might want to use a lubricantSafe lubricants for pregnancy and breastfeedingThe best lubes when you're trying to conceive (TTC)Lubricants for vaginal dryness and vaginismusHow the right lubricant supports vaginal health and pleasureThe science behind Ellechemy – a luxury, evidence-based intimate wellness brandAbout Dr Raelia Lew:Dr Raelia Lew is a Board-Certified Reproductive Endocrinologist, Fertility Specialist, and Director of Women's Health Melbourne. She holds a PhD in Reproductive Genetics and is a Clinical Senior Lecturer at the University of Melbourne. She co-founded Ellechemy to elevate female pleasure through medically-formulated, customisable intimate products.Common Questions Answered in This Episode:What's the best lube for pregnancy?Can lubricant affect fertility when TTC?What lubricants help with vaginal dryness?Are oil-based lubes OK for sensitive skin?How do I choose a safe, effective lubricant?LINKS:womenshealthmelbourne.com.auInstagram @womenshealthmelbourneellechemy.com.auLINKS: Preparing for birth Pelvic health checklist Free 7 Day Trial Pregnancy Workouts Free 7 Day Trial Postnatal Workouts FitNest Mama Website Instagram @kathbaquie.physio 1:1 Consultation with Physio Kath ** This podcast has general information only. Always seek the guidance of your doctor or other qualified health professional with any questions or concerns you may have regarding your health or medical condition.

Welcome back to a newly relaunched ADHD Women's Wisdom episode! These are snippets from previous guests, bringing back their wisdom from the conversation so you can re-process their fascinating insights and essential knowledge to empower you with more awareness and support. If you've had ongoing and unexplained chronic pain, fatigue, gut issues, dizziness, anxiety, dislocations, sprains or aching joints, you may be interested in this week's episode discussing the intersection of Ehlers-Danlos Syndromes, Hypermobility and neurodivergence. This week's Wisdom guest is Dr Jessica Eccles, a Clinical Senior Lecturer at Brighton and Sussex Medical School in the Department of Neuroscience. Her research is on brain-body interactions, particularly related to joint hypermobility. She is an adult liaison psychiatrist and consultant in the Sussex Neurodevelopmental Service and co-lead of their Neurodivergent Brain Body Clinic.Dr. Eccles highlights the prevalence of hypermobility and its association with various symptoms, including chronic pain and fatigue, which can significantly impact individuals' quality of life. Furthermore, she emphasizes the importance of understanding these interconnections, particularly as they relate to neurodivergent individuals who may experience compounded difficulties. On today's ADHD Women's Wellbeing Podcast, Kate Moryoussef and Dr Jessica Eccles talk about: The intricate relationship between neurodivergence and hypermobility. The complexities surrounding hypermobility, including its diagnosis and associated symptoms. Resources that can facilitate understanding and management of hypermobility symptoms. The prevalence of hypermobility in neurodivergent populations emphasises the need for further research. Individuals with hypermobility may experience a spectrum of symptoms requiring tailored management strategies. Advocating for increased awareness and education among healthcare providers regarding hypermobility and its implications. What is Ehlers-Danlos syndrome (EDS)The symptoms, challenges and advantages of hypermobilityThe link between (H)EDS, hypermobility and ADHD/neurodivergenceSide effects of hypermobilityThe interlinks of hypermobility and neurodivergenceHormones, EDS and hypermobility frequency in women and how it presents differently in menFibromyalgia, hypermobility and ADHD connectionsLooking for support? Join my brand-new online coaching programme, From Burnout to Activating Your ADHD Brilliance. Starting on 3rd March, this will be an intimate and personalised coaching experience for only 10 women. Find Kate's popular online workshops and free resources here.Kate Moryoussef is a women's ADHD lifestyle and wellbeing coach and EFT practitioner who helps overwhelmed and unfulfilled newly diagnosed ADHD women find more calm, balance, hope, health, compassion, creativity and clarity. Follow the podcast on Instagram.Follow Kate on Instagram.Companies mentioned in this episode: EDS UK EDS Society SEDS Connective Links referenced in this episode:

In this special extended podcast we have three guests in our virtual studio to examine whether we're getting the messaging about Parkinson's right, be it reporting research findings or at a patient appointment.  With the help of Prof David Dexter, Director of Research at Parkinson's UK and Professor of Neuropharmacology at Imperial College London, Dr Angus Macleod, Honorary Consultant Neurologist at NHS Grampian and Clinical Senior Lecturer at the University of Aberdeen, and former broadcast and print journalist Iain Stephen Morrison, who is the Media and Communications Officer for Parkinson's UK in Scotland, we discuss the difficulties of painting a realistic picture whilst remaining mindful of feelings and still preserving hope. We tackle some difficult topics including prognosis and the mixed messaging surrounding whether one dies with or from Parkinson's, and examine bias in research participation, publicity and public awareness campaigns. 

Welcome to another episode of Bouncing Back: The Personal Resilience Science Insights Podcast, hosted by Joahanna Wickramaratne. Today's discussion takes us to the complex and often misunderstood intersection of eating disorders and body image. Prepare to uncover the hidden connections between these two critical issues and explore ways to foster a healthier relationship with our bodies. Our guest today is Dr. Reza Nejad, the director of Sehat Psychology and a registered clinical psychologist with over 20 years of experience. Dr. Reza Nejad also serves as a Clinical Senior Lecturer at The University of Adelaide's School of Psychology. His extensive expertise in clinical psychology, particularly in the realm of eating disorders and body image, makes him an invaluable voice in today's conversation. In this insightful episode, Dr. Reza Nejad offers a deep dive into the intersection between eating disorders and body image. He defines the intricate relationship between these two concepts and explains why they are often intertwined. Dr. Reza Nejad also addresses how societal standards and media shape our perception of body image, fueling the prevalence of eating disorders. Dr. Reza Nejad discusses the role of platforms in promoting body positivity and challenging harmful beauty standards. He highlights specific terms and phrases commonly used in discussions about body image and eating disorders that need reframing, offering listeners actionable insights to foster a more positive and inclusive dialogue. Follow Dr Reza Nejad's work at: https://sehatpsychology.com.au/   Produced by the Personal Resilience Science Labs, a division of LMSL, the Life Management Science Labs. Explore LMSL at https://lifemanagementsciencelabs.com/ and visit http://pr.lmsl.net/ for additional information about Personal Resilience Science Labs. Follow us on Social Media to stay updated:  YouTube: https://www.youtube.com/channel/UCv1pZy9W9aew6CUK12OeSSQ        Facebook: https://www.facebook.com/personal.resilience.science.labs        Instagram: https://www.instagram.com/resilience.science.labs/      LinkedIn: https://www.linkedin.com/showcase/personal-resilience-science-labs/      Twitter: https://twitter.com/PRScienceLabs      TikTok: https://www.tiktok.com/@resilience.science.labs      Pinterest: https://www.pinterest.com/resiliencesciencelabs/         You can also subscribe and listen to the show on your preferred podcasting platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast/bouncing-back-the-personal-resilience-science/id1649518468         Spotify: https://open.spotify.com/show/48GknFUDXjMsdisT6nRDh2     Amazon: https://music.amazon.com/podcasts/9d79c724-902a-4777-ab4a-b31968806798/bouncing-back-the-personal-resilience-science-insights-podcast     iHeart Radio: https://www.iheart.com/podcast/338-bouncing-back-the-personal-102890036/    Podbean: https://thepersonalresilienceinsights.podbean.com/     PlayerFM: https://player.fm/series/3402362     Podchaser: https://www.podchaser.com/podcasts/bouncing-back-the-personal-res-4930612   

Dr. Uppal Discusses Menstrual Health ChallengesWomenlines welcomes Gynaecologist Dr. Talat Uppal from Sydney! Menstrual cycles can be challenging, particularly for those experiencing heavy menstrual bleeding. Dr. Talat Uppal provides insights on managing this condition, helping women understand the causes and available treatments to improve their quality of life. Menstruation is often seen as an inconvenience, but for millions of women, it can be a disruptive and distressing reality. Heavy menstrual bleeding (HMB) not only causes physical discomfort but can also lead to emotional and social challenges, affecting daily activities, work, and relationships. Today, we are delighted to welcome Dr. Talat Uppal, Director at Women's Health Road in New South Wales, Australia. Dr. Uppal will help us understand the causes of heavy menstrual bleeding and the available treatments, offering insights and solutions for those affected by this condition. Dr. Talat Uppal is the Director at Women's Health Road, an innovative multidisciplinary medical centre for women located in Frenchs Forest, Sydney. She is an esteemed Obstetrician and Gynaecologist, currently serving at both the Northern Beaches and Hornsby Ku-ring-gai Hospitals. Additionally, Dr. Uppal is a Clinical Senior Lecturer in Obstetrics and Gynaecology at Macquarie University. With over a decade of experience, Dr. Uppal previously held the role of Senior Obstetrics Staff Specialist and Clinical Director of Women's, Children & Family Health at Manly and Mona Vale Hospitals. She has also chaired the NSW State Reference Committee and the NSW RANZCOG Education Subcommittee. As a RANZCOG Media Spokesperson, Dr. Uppal is a vocal advocate for women's health. Her special interest lies in supporting the role of General Practitioners within the women's health context. Heavy menstrual bleeding (HMB), also known as menorrhagia, is a common but often misunderstood condition. It affects many women at some point in their lives, significantly impacting their daily activities and overall quality of life. This comprehensive article will delve into the symptoms, causes, and treatment options for heavy menstrual bleeding, providing valuable insights for those experiencing this condition. Heavy menstrual bleeding is defined as excessive menstrual blood loss that interferes with a woman's physical, emotional, social, and material quality of life. Clinically, it is often characterized by: Menstrual periods lasting more than 7 days. Needing to change sanitary protection every 1-2 hours. Passing large blood clots. Symptoms of anemia, such as fatigue or shortness of breath. Recognizing the symptoms of heavy menstrual bleeding is crucial for seeking appropriate treatment. Common symptoms include: Prolonged Bleeding: Menstrual periods that last more than a week. Excessive Blood Loss: Soaking through one or more sanitary pads or tampons every hour for several consecutive hours. Passing Large Clots: Blood clots larger than a quarter during menstruation. Interference with Daily Activities: The need to double up on sanitary protection to control menstrual flow or to change sanitary products frequently, even at night. Symptoms of Anemia: Fatigue, shortness of breath, and pallor, due to significant blood loss.

On today's HEALING 101, I am speaking with Dr Martina Di Simplicio is a Clinical Senior Lecturer in Psychiatry at the Division of Psychiatry, Imperial College London, and Honorary Consultant Psychiatrist in the West London Mental Health Trust. On today's episode we are focusing on self-harm in all it's different forms, I question Martina on why the rates are rising so rapidly, what treatment can be offered to people who self harm and if there are any trends amongst people that tend to self harm. We also discuss interventions such as the IMAGINATOR app for episodic stimulation based self-harm reduction which was built together with an advisory group of young people with lived experience of self harm. Though this might sound like a sombre topic, it's a very important one and I hope you learn as much as I did.More information on Martina: https://www.imperial.ac.uk/people/m.di-simplicioFollow Hurt to Healing on Instagram: @hurttohealingpod--A big thank you our wonderful charity partner Shout. Shout is the UK's first 24/7 mental health text support service so if you're struggling or in need of someone to talk to, please remember to text Shout to 85258. Thank you to our corporate supporter, Brown Advisory, a global investment management firm which is passionate about raising awareness of mental health challenges in order to help people thrive in an ever-changing world. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we talk to Dr Garth Funston, who is a Clinical Senior Lecturer in Primary Care Cancer Research within the Wolfson Institute of Population Health at Queen Mary University of London.Title of paper: Pre-diagnostic prescription patterns in bladder and renal cancer: a longitudinal linked data studyAvailable at: https://doi.org/10.3399/BJGP.2023.0122Previous studies have demonstrated that prescription rates for certain medications increase many months before the diagnosis of some cancers. Determining whether prescribing for common urological clinical features increases in patients with renal and bladder cancer could help us identify opportunities for more timely diagnosis. We found that prescription rates for UTI medications increased 9 months before bladder and renal cancer diagnosis, with an even earlier increase occurring before bladder cancer diagnosis in women (11 months). This indicates that there is a window of opportunity in which investigation and referral could lead to earlier cancer detection in some patients presenting to their GP with features of UTI.

If you've had ongoing and unexplained chronic pain, fatigue, gut issues, dizziness, anxiety, dislocations, sprains or aching joints, you may be interested in this week's episode discussing the intersection of Ehlers-Danlos Syndromes, Hypermobility and neurodivergence. This week's ADHD Women's Wellbeing Podcast guest is Dr Jessica Eccles, a Clinical Senior Lecturer at Brighton and Sussex Medical School in the Department of Neuroscience. Her research is on brain-body interactions, particularly related to joint hypermobility. She is an adult liaison psychiatrist and consultant in the Sussex Neurodevelopmental Service and co-lead of their Neurodivergent Brain Body Clinic.On today's ADHD Women's Wellbeing Podcast, Kate Moryoussef and Dr Jessica Eccles talk about:What is Ehlers-Danlos syndrome (EDS)The symptoms, challenges and advantages of hypermobility The link between (H)EDS, hypermobility and ADHD/neurodivergence Side effects of hypermobility The interlinks of hypermobility and neurodivergence Hormones, EDS and hypermobility frequency in women and how it presents differently in men Fibromyalgia, hypermobility and ADHD connectionsPregnancy and hypermobility Diagnosing neurodivergence and hypermobility Making daily tasks and exercises more mindful to improve chronic painLong covid, fatigue and hypermobility Using pilates to build a stable core to help with hypermobility Protecting ourselves from burnout You can find Dr Eccles here on Instagram.Try Get Dopa here with a 10% discount: https://bit.ly/adhdwomenswellbeing10Additional resources to support you:Claire Smith's bookhttps://gptoolkit.ehlers-danlos.org/https://www.potsuk.org/https://www.sedsconnective.org/Kate Moryoussef is a women's ADHD Lifestyle & Wellbeing coach and EFT practitioner helping overwhelmed yet unfulfilled (many with ADHD like her) women find more calm, balance, health, compassion, creativity and clarity. Have a look at some of Kate's workshops and free resources here.Follow the podcast on Instagram hereFollow Kate on Instagram hereHave a read of Kate's articles in ADDitude magazine here

The publication of this podcast was funded by QIAGEN. Tune in to our latest podcast for valuable insights on non-small cell lung cancer (NSCLC). Esteemed contributors to this discussion include Terri Conneran, a Patient Advocate and founder of KRAS Kickers, and Colin Lindsay, a Clinical Senior Lecturer and Honorary Consultant in Thoracic Medical Oncology at The Christie in Manchester, UK. Both experts underscore the pivotal importance of biomarkers, diagnostic technologies, and collaborative efforts in enhancing survivorship. During this episode, you'll hear about the need for early biomarker testing in NSCLC, along with a forward-looking exploration of the field's future. Lindsay offers an overview of the current treatment landscape for NSCLC, shedding light on issues like late diagnosis and targeted therapies, as well as outlining next-generation sequencing and liquid biopsy as tools to enhance NSCLC testing. Patient experiences are explored, with Conneran sharing her personal journey with diagnosis and treatment. Speaker Bios: Terri Conneran – Patient Advocate and Founder of KRAS Kickers, Charlotte, North Carolina. United States. Colin Lindsay - Clinical Senior Lecturer and Honorary Consultant in Thoracic Medical Oncology at The Christie, Manchester

Starting university or medical school can be a daunting experience for anyone, but when you're the first person in your family to study medicine, it can feel even scarier. In today's episode, we're going to be talking all about what it's like to be a first-generation medical student. We'll start from the very beginning and talk about when we first realised we wanted to study medicine and what it was like to apply. We'll then move on to discussing our time at medical school, and whether we experienced any kind of culture shock when we arrived. We'll finish up by talking about positive changes we'd like to see in medicine, and how our feelings have changed with time. Expert guests: Dr Enam-Ul Haque is a GP Partner in Manchester, as well as a Clinical Senior Lecturer at the University of Manchester. He has a passion for widening participation and equality, diversity and inclusion (EDI) and is the Founder of the National Medical Schools Widening Participation Forum and Co-Chair of the MSC EDI Alliance. Check us out on social media: Twitter: https://twitter.com/BMJStudent Instagram: https://www.instagram.com/bmj_student/ Facebook: https://www.facebook.com/BMJStudent/ This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

I'm your host, psychotherapist Christina Crowe, and I love making invisible things visible. Today I have the privilege of speaking with global hyper-mobility experts Dr. Nimish Mittal and Dr. Jessica Eccles, and we break down some of the mystery behind the connections between hyper-mobility syndromes, Ehlers Danlos Syndrome(s) and neurodivergent conditions like ADHD, Autism and Tourette's. Stay tuned for an information packed episode today that will help so many people living with connective tissue and sensory disorders,  find both validation and direction. Today we: We define what EDS is and isn't, Talk about how it's different from 'hyper-mobility'?, Learn about the connection between EDS, ADHD and Autism, and Learn from the doc's how can patients talk to their doctors effectively about the symptoms they are experiencing. Resources mentioned in the show:  Learn more about Dr. Nimish Mittal's GoodHope Ehlers-Danlos Syndrome Clinic in Toronto, Dr. Eccles recent research: Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain, Free Downloadable Symptom Tracker from Dig a Little Deeper, to help share information with your primary care practitioner. The EDS Society website Resources, and Understanding Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder', a new book by Claire Smith Learn about the presentation, symptoms and how to check if you might have a Hypermobility Spectrum Disorders (HSD) , Learn about the 13 subtypes of Ehlers-Danlos syndromes (EDS), Use the discount code ‘PEBBLE' at checkout, for 15% off on DIY*ADHD:Couples. About our guests:   Dr. Nimish Mittal is an Assistant Professor at the Temerty Faculty of Medicine, University of Toronto, Division of Physical Medicine and Rehabilitation. Dr. Mittal holds a cross-appointment in the Department of Anesthesiology and Pain Medicine and the Faculty of Kinesiology and Physical Education. He holds a Master's in Health Research Methodology. Dr Jessica Eccles is a Clinical Senior Lecturer at Brighton and Sussex Medical School in the Department of Neuroscience.  Her research is in brain-body interactions, particularly related to joint hypermobility.  She is an adult liaison psychiatrist and consultant in the Sussex Neurodevelopmental Service and co-lead of their Neurodivergent Brain Body Clinic.  Find Christina (CRPO #003908): Website | Meet the Team | DIY*ADHD course | Instagram | TikTok A gentle reminder that this is not therapy, and Christina is not your therapist. If you need more one on one support or treatment, please check out the links posted in the Show info and episode notes on the main podcast webpage.  LISTEN OR SUBSCRIBE for free in your favourite podcast app: Apple Podcasts | Spotify | Google Podcasts | Overcast | Stitcher | RSS --- Send in a voice message: https://podcasters.spotify.com/pod/show/christinacrowe/message

2022 was a decidedly volatile year in the field of psychiatry. In July, a study led by Dr Joanna Moncrieff found that there was no convincing evidence that depression is connected with low serotonin, let alone caused by it. In November, while the psychiatric profession and, perhaps more significantly, the millions of people taking antidepressants were still reeling from Moncrieff's findings, a study co-authored by Dr David Erritzoe was published which provided the first direct evidence that serotonin release is blunted in the brains of people with depression. BizNews spoke to Erritzoe who explained the findings of the brain imaging study which is sparking debate within psychiatry about the so-called serotonin hypothesis of depression and challenging the findings of Moncrieff's controversial study. Erritzoe, who is the Clinical Director in Centre for Psychedelic Research and Clinical Senior Lecturer in Psychiatry at Imperial College London, also provided fascinating insight into Imperial's novel studies investigating the brain mechanisms and therapeutic potential of MDMA, ketamine and classic psychedelics. Learn more about your ad choices. Visit megaphone.fm/adchoices

My guest today is Father Laurence Freeman OSB, a Benedictine monk of the Congregation of Monte Olivetto Maggiore in Italy.  Fr Laurence was educated by the Benedictines and studied English Literature at Oxford University. He is the Director of the World Community for Christian Meditation (WCCM) an inclusive contemplative  community based in Bonnevaux. Fr Laurence is a prolific author. His books include: Light within, the Selfless Self, Your Daily Practice, Jesus: the Teacher Within, First Sight: The Experience of Faith, Web of Silence and Good Work: Meditation for Personal and Organizational Transformation. He has collaborated with the Dalai Lama on many dialogues and on the ground breaking book The Good Heart. In addition to his work for the contemplative renewal of Christianity he leads dialogues and peace initiatives, seeing meditation as opening the common ground of all humanity.To Fr Laurence meditation is central because it is foundational, because it is a daily practice for him. He recommends that people meditate twice a day, morning and evening, which has a transformative effect upon our sense of time and, and our way of living. At his center they meditate four times a day. Many people, when they I first began, feel that they don't have time to meditate. But  the time that you give to the meditation comes back. And one has to be patient.And the interesting discovery is that when we enter solitude, for example, in the time of meditation, and we leave images and conversations with ourselves behind then we find ourselves more and more deeply in this solitude. And the curious and wonderful discovery is  that accepting your uniqueness is also the means to much deeper and richer sense of relationship to others. Solitude is the cure for loneliness. Loneliness is a failed solitude. It's the failure or the inability to really be oneself and accept oneself in one's uniqueness.God does not allow evil to happen. But God is in the suffering of those who are subjected to that evil. God is omnipresent. God is around a being and God is presence. There is this very challenging and almost terrible saying of Jesus. He says, God is like the sun that shines on good and bad or on the ungrateful and the wicked.God is being and God is your being. In the silence, in the stillness of meditation, you are being with God, God is being with you, but not in a way that you can psychologize. My guest next week will be Dr Jessica Eccles MB, ChB, Dip(French), MA, MSc, MRCPsych, PhD, PGCert HE, Clinical Senior Lecturer and MQ Arthritis Research UK Fellow. We shall talk about philosophy of mind and brain-body interactions and the relationship between joint hypermobility, autonomic dysfunction and psychiatric symptomsIf you liked this podcast please tell your friends about it, subscribe to this podcast wherever you listen to podcasts and/or write a brief note on apple podcasts, check out my blogs on Psychology Today at https://www.psychologytoday.com/intl/contributors/thomas-r-verny-md

Dr. Lupe Taumoepeau is a Vascular and Transplant surgeon at Wellington Hospital and Clinical Senior Lecturer at the University of Otago. She is the first New Zealand female vascular surgeon and only Pacific Island vascular surgeon in Australasia. She received her fellowship from the Royal Australasian College of Surgeons in 2014 after completing training throughout New Zealand and Queensland, Australia. Lupe is actively involved in mentoring Pacific Island students and female junior doctors considering a career in surgery, and has a strong interest in prevocational medical education. Outside of medicine, Lupe enjoys cheering for her son on the side of the soccer field and basketball court, exploring the outdoors with her family and dog and is looking forward to getting back to Tonga once the borders have re-opened.In this episode, we discuss her journey from her roots in Tonga to transplant and vascular surgery in Wellington. We delve into the importance of mentorship in her life, the legacy she carries from her grandfather, and the cultural values she carries with her in her practice. Finally, we discuss her work in vascular and transplant surgery, and what it feels like to be the first, and only, Pacific Island vascular surgeon. Support the showAs always, if you have any feedback or queries, or if you would like to get in touch with the speaker, feel free to get in touch at doctornos@pm.me. Audio credit:Bliss by Luke Bergs https://soundcloud.com/bergscloudCreative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0Free Download / Stream: https://bit.ly/33DJFs9Music promoted by Audio Library https://youtu.be/e9aXhBQDT9Y

An interview with Dr Chris Kosmidis, Clinical Senior Lecturer at Wythenshawe Hospital and Aspergillosis centre about aspergillosis. Divided into two parts, the first part of our discussion covers ABPA for the generalist, and is a goldmine of information for diagnosing, treating and monitoring response in these patients. I now feel comfortable interpreting the serology, prescribing antifungals where appropriate and how to look out for a relapse which is a long way from where I started!References for this podcast include:Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29. PMID: 25354514.Godet et al. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial. Eur Respir J. 2022 Jun 16;59(6):2102218. doi: 10.1183/13993003.02218-2021. PMID: 34764182.Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Garg M, Aggarwal AN, Chakrabarti A. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2021 Sep 9;59(4):2101787. doi: 10.1183/13993003.01787-2021. PMID: 34503983.How do we treat aspergillosis? - Dr Chris Kosmidis - YouTubeSupport the show

In our latest episode, we welcome Dr. Mikael Sodergren, Medical Cannabis Research Group Lead at Imperial College London and Managing Director at Sapphire Medical Clinics.We examine how clinical trials and real-world evidence can be used to prove the efficacy of cannabis-based medicines, as well as the challenges associated with applying traditional licensing and regulatory models to these novel medicines.

Send us a Text Message.Welcome to the latest episode of BLA Connect, A Clear Voice, where we join host, Natalie Watson and Mr James O'Hara, Clinical Senior Lecturer at Newcastle University and Honorary Consultant Otolaryngologist at Newcastle-upon-Tyne Hospitals, to talk about a topic that is incredibly common in the laryngology clinic – persistent throat symptoms.James and Natalie discuss the many and varied causes of an irritated larynx and persistent throat symptoms, and the historic low-level of evidence for standard treatments such as proton pump inhibitors. The results of the TOPPITS (Trial of Proton Pump Inhibitors) run by James O'Hara with Prof Janet Wilson showed that these were no more effective than placebo treatment. So where does that leave us? Treatment is moving towards the use of alginates, such as Gaviscon, and James is involved in a new pre-clinical trial, (TALGITS – Trial of Alginates and Throat Symptoms) to look at the effectiveness of these in treating persistent throat symptoms and hopefully improve the management of these symptoms in primary care.Ultimately, we all want to provide the best care for patients and providing a diagnosis or label for their symptoms can seem a good way of doing this. However, the lack of clear treatment pathway for persistent throat symptoms can lead to unnecessary worry with patients often referred to Head and Neck Cancer clinics. When we do see patients in clinic, James and Natalie emphasise the importance of letting the patient talk, being honest about the lack of evidence-based treatment in this area, considering comorbidities such as fibromyalgia and chronic pain symptoms, and discussing behavioural modifications and strategies for how patients can take ownership of and manage their own symptoms.The take home message from this episode must be to always question and improve what we do for the patient's benefit. Listen to previous episodes of this podcast from the podcast provider of your choice and on our BLA Connect App. If you have any suggestions for topics you would like to hear about or guests you want to hear from please do get in touch at enquiries@britishlaryngological.org. You can also support us by hitting Like, Subscribe or leaving a review for this podcast with your provider. Thank you for listening. Contact Information Visit www.brContact InformationVisit www.britishlaryngological.org or download BLA Connect from your app store for further information and details on becoming a BLA member.Register for Cutting Edge Laryngology 2024, 2-4 October 2024, at the Royal Society of Medicine London, here. Email: enquiries@britishlaryngological.org for any questions or topic suggestions you may have for future episodes. This show is brought to you by the BLA, you can follow us on Twitter, Facebook, Linkedin and Instagram hosted by Natalie Watson @surgeonsinger produced and directed by Heather Pownall of Heather's Media Hub Ltd. The opinions of our host and guests are their own; The BLA does not endorse any individual viewpoints, given products or companies. If you enjoyed this podcast, please rate, review and subscribe with the podcast provider of your choice.

There are now a number of biological indicators for the potential development of long covid. Immunologist Onur Boyman of Zurich University Hospital and Claire Steves, Clinical Senior Lecturer at King's College London strives to tell us how pinpointing these factors is now helping in the development of strategies to predict the syndrome and prepare treatment. The James Webb telescope has reached its final orbit. The years of planning, preparation and rehearsal seem to have paid off. The telescope is now ready to begin its mission of looking back into the early universe. BBC Science correspondent Jonathan Amos has followed the mission. The widely held view that human development was propelled by our ancestors developing a taste for meat is being questioned by a new analysis of the fossil record. Paleoanthropologist Andrew Barr of George Washington University suggests part of the reason for this assumption is the sampling method, actively looking for evidence to support the hypothesis. And Michael Boudoin of Lille University has led a team of physicists who have produced the longest-lasting soap bubble ever – they managed to prevent the bubble from popping for well over a year. Also, How is a small budget pocket radio able to recreate all the atmosphere and sounds of a football match? CrowdScience listener Andy wants to know about the science enabling his radio listening, so presenter CrowdScience Geoff Marsh sets off - microphone in hand - to follow the journey of sound on the radio. Starting with the microphone, Geoff learns how acoustic energy is converted into electrical signals. Then BBC World Service presenter Gareth takes Geoff to a little-known room in the BBC called the Radio Shack. Gareth demonstrates how these electrical signals are attached to radio waves before being sent over the airwaves and they take a radio kit apart to understand how these waves are received and converted back into sound waves. Geoff talks to a speech and hearing specialist who, through the use of auditory illusions, shows Geoff that our brains are often filling in the gaps of lower quality audio. Finally, Geoff visits an acoustic lab at Salford University where he hears a demonstration of ‘object based audio'. This technology could enable us to create our own bespoke mix of dramas and sports, such as heightening the commentary sound or choosing to hear just the crowd, just by using the everyday speakers many have lying around them, such as mobile phones. (Image credit: Horacio Villalobos/Getty Images)

There are now a number of biological indicators for the potential development of long covid. Immunologist Onur Boyman of Zurich University Hospital and Claire Steves, Clinical Senior Lecturer at King's College London strives to tell us how pinpointing these factors is now helping in the development of strategies to predict the syndrome and prepare treatment The James Webb telescope has reached its final orbit. The years of planning, preparation and rehearsal seem to have paid off. The telescope is now ready to begin its mission of looking back into the early universe. BBC Science correspondent Jonathan Amos has followed the mission. The widely held view that human development was propelled by our ancestors developing a taste for meat is being questioned by a new analysis of the fossil record. Paleoanthropologist Andrew Barr of George Washington University suggests part of the reason for this assumption is the sampling method, actively looking for evidence to support the hypothesis. And Michael Boudoin of Lille University has led a team of physicists who have produced the longest-lasting soap bubble ever – they managed to prevent the bubble from popping for well over a year. (Image credit: Horacio Villalobos /Getty Images) Presenter: Roland Pease Producer: Julian Siddle

In this episode of Psych Matters, Associate Professor Mat Coleman and his guests discuss Smoking Cessation & E-Cigarettes.Joining in the discussion are Professor Hayden McRobbie and Dr Mark Montebello.Associate Professor Mat Coleman is the Clinical Director of the Great Southern Mental Health Service (WA Country Health Service) based out of Albany WA. He is also the inaugural chair of Rural and Remote Mental Health Practice for the Rural Clinical School WA (University of Western Australia) and is a Commissioner with the National Mental Health Commission. Mat is a member of the Faculty of Addiction Psychiatry, and the Child and Adolescent Faculty of the RANZCP and is the current chair of the Section of Rural Psychiatry. Professor Hayden McRobbie, MB ChB (Otago), PhD (London), FASLMHayden has worked in the field of behavioural medicine for more than 20 years and is a senior clinician with a specialist interest in lifestyle medicine. He holds a medical degree from the University of Otago, a doctorate from the University of London, and is Professor in Public Health Interventions at the National Drug and Alcohol Research Centre, UNSW, and a Fellow of the Australasian Society for Lifestyle Medicine. Hayden has played a key role in Tobacco Control in New Zealand, and his current work includes prevention and management of long-term conditions, with a particular focus on improving health outcomes for Māori in New Zealand. Hayden McRobbie has received honoraria for speaking at smoking cessation meetings and attending advisory board meetings that have been organised by Pfizer Dr Mark Montebello is the Clinical Director of the Northern Sydney Local Health District Drug and Alcohol Service. He is a Psychiatrist, an Addiction Medicine Specialist, a Conjoint Senior Lecturer at the National Drug and Alcohol Research Centre, and a Clinical Senior Lecturer, Discipline of Addiction Medicine, Northern Clinical School at the University of Sydney. Dr Montebello's research interests include novel treatments for substance use disorders including nicotine use disorder withdrawal management in drug and alcohol settings. He was the Psychiatry Board Member for the Australian Association of Smoking Cessation Professionals. Mark Montebello has received honoraria for speaking at smoking cessation meetings and attending advisory board meetings that have been organised by Pfizer.Feedback:If you have a topic suggestion or would like to participate in a future episode of Psych Matters, we'd love to hear from you.Please contact us by email at: psychmatters.feedback@ranzcp.orgDisclaimer:This podcast is provided to you for information purposes only and to provide a broad public understanding of various mental health topics.  The podcast may represent the views of the author and not necessarily the views of The Royal Australian and New Zealand College of Psychiatrists ('RANZCP'). The podcast is not to be relied upon as medical advice, or as a substitute for medical advice, does not establish a doctor-patient relationship and should not be a substitute for individual clinical judgement.  By accessing The RANZCP's podcasts you also agree to the full terms and conditions of the RANZCP's Website. Expert mental health information and finding a psychiatrist in Australian or New Zealand is available on the RANZCP's Your Health In Mind Website.

This episode of Tuning Healthcare features Dr. Matthew Harris, Clinical Senior Lecturer in Public Health, in the department of Primary Care and Public Health at Imperial College London. Dr. Harris is an honorary consultant in public health medicine for the Imperial College Healthcare NHS Trust. His research spans global health, innovation, diffusion, primary care and health services. Dr. Harris has worked for several years as a primary care physician in Brazil, a WHO polio consultant in Ethiopia, an HIV technical consultant in Mozambique and the global health advisor to the UK Department of Health. Dr. Harris discusses The benefits, biases and challenges for adopting frugal innovations and community health solutions in leading healthcare markets. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr Tina Ryan talks to Dr Rosie Baruah about microaggressions, how to recognise them and actions you can take. Dr Baruah is a Consultant in Intensive Care Medicine, Western General Hospital and Hon. Clinical Senior Lecturer, University of Edinburgh -- The Seven Acts of Allyship -- Appetite – Do you have the appetite to immerse yourself in the complex, emotive world of race equality? Ask – Ask questions about race, be curious, read, learn and educate yourself. Accept – Accept there is really a problem. More data aren't needed. Acknowledge – Openly acknowledge that the problem needs to be dealt with. Apologise – Express sympathy that racism is affecting people of certain races. Assume – Don't. Instead develop informed views by seeking to understand individuals. Action – Take demonstrable action steps to establish equality and be accountable. 7 A's Infographic - https://twitter.com/yvonnecoghill1/status/1280744970102636550 https://twitter.com/rosieICM

This episode of Tuning Healthcare features Dr. Matthew Harris, Clinical Senior Lecturer in Public Health, in the department of Primary Care and Public Health at Imperial College London. Dr. Harris is an honorary consultant in public health medicine for the Imperial College Healthcare NHS Trust. His research spans global health, innovation, diffusion, primary care and health services. Dr. Harris has worked for several years as a primary care physician in Brazil, a WHO polio consultant in Ethiopia, an HIV technical consultant in Mozambique and the global health advisor to the UK Department of Health. Dr. Harris discusses The benefits, biases and challenges for adopting frugal innovations and community health solutions in leading healthcare markets

Venetoclax in combination with FLAG-IDA chemotherapy shows safety and promising efficacy in both untreated and relapsed/refractory AML in this phase 1b/2 study, providing a strong rationale for phase 3 trials incorporating this agent in patients fit for intensive therapy.   TRANSCRIPT This JCO Podcast provides observations and commentary on the JCO article “Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia” by DiNardo et al. My name is Richard Dillon, and I am a Clinical Senior Lecturer in Cancer Genetics at King's College London and Consultant Hematologist at Guy's Hospital, London, UK. My oncologic specialty is Adult Acute Myeloid Leukaemia. I'd like to note that my institution receives research funding support from Abbvie.   The recently published VIALE-A and VIALE-C trials demonstrated significant efficacy of venetoclax when added to low dose chemotherapy in patients with newly diagnosed AML who cannot receive intensive chemotherapy due to their age or comorbidities. Venetoclax has now become the standard of care for these patients, and there is growing interest in investigating how the potent anti-leukemic efficacy of this agent can be exploited in younger patients, who are fit to receive intensive treatment with curative intent. To date, only a small number of studies have addressed this important question.   In the front-line setting, a phase 1b study performed in Australia by Chua and colleagues tested the addition of 14 days of venetoclax to a regimen consisting of 7 days of infusional cytarabine and two doses of idarubicin for patients aged over 65 with previously untreated AML. This was well tolerated, and the overall response rate was 72%: 97% in patients with de-novo and 43% in patients with secondary AML.   Karol and colleagues from St. Jude's Children's Hospital performed a phase 1 study testing the combination of 28 days of venetoclax with varying doses of cytarabine and idarubicin in children with relapsed or refractory AML. At the recommended phase 2 dose, which was 600mg of venetoclax and eight doses of 1000mg per square meter cytarabine, with or without idarubicin, the overall response rate was 70%. Importantly, for children who received a lower dose of cytarabine (20 doses of 100mg per meter square), the response rate was markedly lower at 33%.   In the study referred to in this podcast, DiNardo and colleagues combined venetoclax with the FLAG-IDA regimen. FLAG-IDA is an intensive chemotherapy schedule incorporating high-dose cytarabine, typically used for patients with refractory or relapsed AML. And in this setting, overall response rates between 50 and 60% have been reported. FLAG-IDA has also been used in patients with newly diagnosed AML—for example, in the UK NCRI AML15 study, where the overall response rate was 86% and 5-year overall survival was 44%.   The current study comprised a phase 1b dose escalation in patients with relapsed or refractory disease, followed by a phase 2 dose expansion in both newly diagnosed and relapsed or refractory patient cohorts. In total, 68 patients were treated with the venetoclax FLAG-IDA combination. As expected, this combination was severely myelosuppressive, and during the dose-escalation phase, a number of alterations were made to the schedule to mitigate this toxicity, including reductions in the cytarabine dose to 1.5g per meter square and the length of venetoclax treatment to two weeks in induction and one week in consolidation. With these modifications, hematological toxicity at the recommended phase 2 dose was manageable. The time to count recovery was 31 days for previously untreated patients and 37 days for patients with relapsed or refractory disease and was not prolonged in patients who had undergone previous allogeneic stem cell transplantation. Haematological toxicity was more severe in the second cycle of treatment with 59% of patients experiencing delayed count recovery beyond day 45. Nevertheless, day 60 mortality was low at 4.4%.   The response rates observed in this study were impressive. At the recommended phase 2 dose, 97% of newly diagnosed and 70% of relapsed or refractory patients had achieved a composite complete remission, which included CR, CRi and CR with partial hematological recovery, CRh. CR or CRi was achieved in 72% and 48%, and MRD negativity by flow cytometry was achieved in 89% and 48% of patients with newly diagnosed and relapsed or refractory disease, respectively.   Although the number of patients was too small to reliably identify molecular and cytogenetic groups with a differential response, patients with relapsed or refractory AML with genotypes previously reported to be particularly sensitive to venetoclax containing regimens, which are NPM1, IDH1 and IDH2, appeared to have a particularly high rate of response with a composite CR rate of 100% and 12-month overall survival rate of 83%. In addition, the 7 patients with MLL rearrangements appeared to do particularly well, with a composite CR rate of 100% and 80% of patients testing negative for MLL fusion transcripts by PCR. One-year overall survival in this group was 80%, possibly highlighting MLL-rearranged leukemias as an additional group with particular sensitivity to BCL2 inhibition. This signal was not apparent in earlier trials using low doses of chemotherapy, perhaps because MLL rearrangements are much less frequent in older adults, or alternatively perhaps because this lesion requires higher doses of chemotherapy to synergise with BCL2 inhibition to overcome the apoptotic threshold.   On the other hand, there appeared to be some groups with less favorable responses. Patients with core-binding factor leukemias appeared to do less well than expected, with a median overall survival time of 7.6 months. Patients with these leukemias were excluded from the earlier phase 2 and 3 studies of venetoclax, so there is no prior clinical data regarding their sensitivity to BCL2 inhibition; however, this finding does concur with in vitro data suggesting a lack of sensitivity.   The outcomes for patients with TP53 mutations were disappointing with a median overall survival time of 9 months for newly diagnosed and 7 months for relapsed patients. Interestingly, even in the four TP53-mutated patients who tested MRD negative by flow cytometry, the TP53 mutation was still detectable by next-generation sequencing after treatment. The number of patients in these groups were small and will require confirmation in larger studies; however, alternative treatment strategies might be required for these patients.   Overall, these results appear extremely promising and suggest that venetoclax may have significant activity when used with intensive induction or salvage chemotherapy schedules in younger adults. This now needs to be confirmed in randomized trials comparing intensive chemotherapy with and without venetoclax in both the front-line and salvage settings. If these trials are positive, further comparative studies will be needed to define the best chemotherapy schedule to combine with venetoclax. While limited data indicate that standard doses of cytarabine are likely inadequate, the optimal dose of cytarabine, and the additional value of fludarabine and anthracyclines remains to be defined. Nevertheless, the study by DiNardo and colleagues represents a significant step forward in the deployment of venetoclax in young fit adults, with the hope that this will increase the rate of long-term cures from this aggressive and frequently fatal hematological malignancy.   This concludes this JCO Podcast. Thank you for listening.

This week regular guest host Dr Anna Volkmer talks with the joint co-ordinating editors of the Cochrane Dementia Group. Listen to hear about the work of Cochrane, how they support evidence-informed decision making in healthcare, their work on undertaking systematic reviews and how you could become involved. This weeks guests are: Dr Terry Quinn, Clinical Senior Lecturer, Honorary Consultant and Joint co-ordinating editor of Cochrane Dementia Group. Terry is a clinician working in stroke and older adult services in Glasgow is also the national lead for ageing research in Scotland. Dr Jenny McCleery, Consultant Psychiatrist & Joint co-ordinating editor of Cochrane who describes herself as first, and foremost a Clinician. In her day-job she works as part of a community team for Older Adults at Oxfordshire Health NHS Foundation Trust. Cochrane Dementia and Cognitive Improvement Group, is part of Cochrane's Mental Health and Neuroscience Network. They aim is to provide the highest quality evidence about the care and medical treatment of people with dementia, delirium and other cognitive disorders, and about the diagnosis and prevention of these disorders. This is done through undertaking systematic reviews addressing questions which are important to patients, their families, and healthcare professionals from all disciplines. _________________________ You can read more about the scope of Cochrane Dementia and their work here: https://dementia.cochrane.org/our-work A transcript of this podcast is also available here https://www.dementiaresearcher.nihr.ac.uk/podcast-cochrane-dementia-and-cognitive-improvement-group Dr Terry Quinn Bio https://www.dementiaresearcher.nihr.ac.uk/profile-dr-terry-quinn/ Dr Jenny McCleery Bio https://www.dementiaresearcher.nihr.ac.uk/profile-dr-jenny-mccleery/ _________________________ Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode. Register on our website to receive your weekly bulletin, and to access more great content – blogs, science, career support + much more https://www.dementiaresearcher.nihr.ac.uk This podcast is brought to you in association with Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.

Antonia Ho, Infectious Diseases Physician and Clinical Senior Lecturer at the University of Glasgow Centre for Virus Research, discusses Nicola Sturgeon's imminent announcement on restrictions in Glasgow.

Join Joseph Ischia, Amy Teh and Nick James as they discuss radiation to the prostate in metastatic prostate cancer. Dr Amy Teh is the Lead Regional Radiation Oncologist at the ICON Cancer Centre for NSW/ACT, a consultant Radiation Oncologist at the Sydney Adventist Hospital and a Clinical Senior Lecturer at the Sydney Medical School, The University of Sydney. A member of TROG and ANZUP Clinical Trials Group, Dr Teh is lead site-investigator for the RAVES, ENZARAD, DASL-HiCap prostate cancer trials at the Sydney Adventist Hospital and has led the Prostate Brachytherapy Program at the Sydney Adventist Hospital, and also the Radiation Oncology Research Committee Co-Chair for the ICON Cancer Centre. Professor James is Consultant in Clinical Oncology at the Queen Elizabeth Hospital Birmingham and Professor of Clinical Oncology at the University of Birmingham. Professor James is internationally renowned for his work in Urological Cancer, particularly on the ground-breaking STAMPEDE trial, which has been used to evaluate, to date, 10 different therapies for advanced prostate cancer in more than 10,000 men. He is a regular educational speaker at conferences worldwide, recently including the American Society of Clinical Oncology, European Society of Medical Oncology and European Association of Urologists Annual Meetings. Results from STAMPEDE with both first line docetaxel chemotherapy and abiraterone have shown that big survival gains can be made by using existing treatments in novel settings. These findings have been practice changing worldwide.

Dr Kim Linton presents a podcast on the BSH Guideline on the investigation and management of follicular lymphoma. Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a chronic, relapsing, indolent condition with long overall survival (OS). Most people affected have advanced disease at presentation; symptoms may include B symptoms (i.e. fever, night sweats and weight loss), fatigue and the local mass effect of lymph node enlargement. However, many people are asymptomatic at presentation. Some people are observed without treatment according to a ‘watch and wait' policy (see section Management of patients with newly diagnosed FL). In contrast to this, over a period of many years, 20–30% of patients will die from refractory FL or following transformation of their disease to high‐grade lymphoma.1 Prognostic indices may help discriminate between risk groups (see section Prognostic factors in FL). Dr Linton discusses the guidelines four main focus areas: 1) Important changes on the use of PET scanning. 2) Advances in the upfront management of patients with asymptomatic and symptomatic advance stage disease.  3) High risk disease in high grade transformation. 4) Advances in the management of relapse with some horizon scanning of promising drugs in development Dr Kim Linton is Consultant Medical Oncologist at Christie NHS Foundation Trust and Clinical Senior Lecturer at the University of Manchester.

On this episode of Policy Forum Pod, our panel - Sharon Bessell, Arnagretta Hunter, and John Falzon - examine Australia’s first budget in the wake of the COVID-19 crisis and ask whether it lays the groundwork for a more prosperous and just nation.The Australian government may have spent big in this federal budget, but does it deliver the right outcomes for the country’s long-term future? Has the government missed a once-in-a-generation chance to address some of the structural challenges Australia faces, particularly in regards to climate and inequality? And what other options might Treasurer Josh Frydenberg have considered in perhaps the most important budget in the lifetimes of most Australians? On this Policy Forum Pod, we’re joined by pod regulars Professor Sharon Bessell, cardiologist and Clinical Senior Lecturer at ANU Medical School Dr Arnagretta Hunter, and sociologist Dr John Falzon to discuss the budget and whether this was a missed opportunity to create a more just nation.Sharon Bessell is Professor of Public Policy and Director of Gender Equity and Diversity at Crawford School of Public Policy at The Australian National University (ANU).Arnagretta Hunter is a cardiologist, physician, and a Senior Clinical Lecturer for The Australian National University Medical School.John Falzon OAM is Senior Fellow, Inequality and Social Justice at Per Capita. He is also a sociologist, poet, and social justice advocate, and was national CEO of the St Vincent de Paul Society from 2006 to 2018.Martyn Pearce is a presenter for Policy Forum Pod and the Editor of Policy Forum.Policy Forum Pod is available on Acast, Apple Podcasts, Spotify, Stitcher, Subscribe on Android or wherever you get your podcasts. We’d love to hear your feedback for this podcast series! Send in your questions, comments, or suggestions for future episodes to podcast@policyforum.net. You can also Tweet us @APPSPolicyForum or join us on the Facebook group. See acast.com/privacy for privacy and opt-out information.

Dr. Posporelis is a Consultant Liaison Neuropsychiatrist at King’s College Hospital London and an Hon. Clinical Senior Lecturer at the IoPPN. Check out his webinar series Braincast here - https://maudsleylearning.com/insights/braincast-webinar-series/Interviewed by Dr. Alex Curmi - Give feedback here - podcast@maudsleylearning.com - Follow us here: Twitter @maudsleypodcast Instagram @maudsleylearningpodcast

In this week’s episode we discuss Vietnam’s response to the COVID-19 pandemic and antimicrobial drug resistance with Dr Guy Thwaites, Director of the Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Program in Vietnam, Dr Thu Anh Nguyen, Country Director, Woolcock Institute and Clinical Senior Lecturer at University of Sydney and Dr Gregory Fox, Project lead for the Indo-Pacific Centre for Health Security’s AMR V-RESIST project in Vietnam and Clinical Academic Lead (Research) for the Faculty of Medicine and Health at Cumberland Campus.Since this interview was recorded, Vietnam has recorded a large outbreak in the coastal city of Da Nang. As discussed by our guests, the government is taking early action when cases are identified. In the case of Da Nang they imposed an immediate lockdown and have launched widespread testing of the city’s 1.1 million residents.

The RACS Morbidity Audit and Logbook tool (MALT) has been useful to electronically log procedures, conduct self-audit and peer-review audit. Paediatric surgeon Mr Paul Jackson uses MALT for recording his own personal data as a surgeon as well as mentoring trainees by examining their data. Mr Jackson works as a specialist Paediatric Surgeon and Paediatric Urologist at Wellington Children's Hospital, New Zealand. He is also a Clinical Senior Lecturer for the School of Medicine & Health Sciences at the University of Otago in Wellington. In this episode he explains the benefits of MALT for both mentors and their trainees. See omnystudio.com/policies/listener for privacy information.

Mr. Alex Liddle (Imperial College) discusses how we can improve outcomes in Total Knee Replacement surgery. Mr Alex Liddle is a Clinical Senior Lecturer in Orthopaedic Surgery at Imperial College whose principal interest is in the improvement of joint replacement surgery through the use of big data and new technologies. He previously undertook a DPhil (PhD) at the Univeristy of Oxford before becoming NIHR Clinical Lecturer at University College London, based at the Institute of Orthopaedics and Musculoskeletal Sciences at the Royal National Orthopaedic Hospital.

Arnagretta Hunter is a cardiologist based in Canberra and a Clinical Senior Lecturer at the Australian National University Medical School. She is also Human Futures Fellow at the ANU College of Health and Medicine and part of the Commission for the Human Futures, an ANU initiative which brings together researchers and thinkers to promote ways we can prevent human extinction. With Arnagretta, we talked about growing up on a farm, the impact of the climate crisis on human health, science denial in politics, and the powers of imagination, utopia and dystopia for change. References mentioned during this episode: - Commission for the Human Future - Doctors for the Environment Australia - Australia21 - Global Green and Healthy Hospitals - Climaginaries - Surviving & Thriving in the 21st Century, Commission for the Human Future - Doctors need to meet challenge of climate change, InSight+ - The carbon footprint of Australian health care, The Lancet - We Can Waste Another Crisis, or We Can Transform the Economy, Jacobin Mag - 'Cashed-up activists’ should not be able to hold up developments, Australia's resources minister says, The Guardian - Yuval Noah Harari - From What Is to What If: Unleashing the Power of Imagination to Create the Future We Want, Rob Hopkins - The Uninhabitable Earth: Life After Warming, David Wallace-Wells - Men at Work: Australia’s Parenthood Trap, Annabel Crabb - Climate Change and the People's Health, Sharon Friel - How Democracy Ends, David Runciman - Agency, William Gibson

This is a conversation between Dr Zudin Puthucheary, Senior Lecturer and Consultant in Intensive Care Medicine, Dr Jim Buckley, Consultant in Intensive Care medicine, and Dr Brijesh Patel, Clinical Senior Lecturer and Consultant in Cardiothoracic Intensive Care.  Some of the learning from the early stages of this virus and how it is impacting our patients and our service.

This week on Policy Forum Pod, we tackle key questions about the novel coronavirus outbreak – what is the virus, how are countries responding, and how do we address the spread of misinformation when public tensions are running high.The coronavirus outbreak is rapidly evolving, with new information coming to light each day. With the level of uncertainty about the disease, misinformation is also spreading fast. While orchestrating major public health responses is difficult at the best of times, how can authorities ensure the public are well informed when falsehoods are spread so easily via social media? How appropriate and effective are the responses we’ve seen from international governments so far? And how important is it to maintain strong multilateral institutions to address global health crises? On this week’s pod, we speak to two public health experts – Professor Martyn Kirk and Dr Nick Coatsworth – and a China scholar – Yun Jiang – to unpack these issues. Martyn Kirk is a National Health and Medical Research Council Career Development Fellow and Professor of applied epidemiology at The Australian National University Medical School. He has worked for over 20 years in state, territory, and federal health departments in the areas of infectious disease surveillance and investigation.Nick Coatsworth is a Consultant Physician in infectious disease medicine at Canberra Hospital, a Clinical Senior Lecturer in Medicine at The Australian National University Medical School, and a PhD scholar at ANU School of Regulation and Global Governance (RegNet). He was President of Medecins Sans Frontieres Australia from 2010 to 2011.Yun Jiang is a researcher at the Australian Centre on China in World and Co-Editor of China Neican, a newsletter that decodes China issues with concise, timely, and policy-focused analysis. Her research interests include geo-economics, Australia-China relations, and Chinese-Australians.Martyn Pearce is a presenter for Policy Forum Pod and the Editor of Policy Forum.Policy Forum Pod is available on Apple Podcasts, Spotify, Stitcher, Subscribe on Android or wherever you get your podcasts. We’d love to hear your feedback for this podcast series! Send in your questions, comments, or suggestions for future episodes to podcast@policyforum.net. You can also Tweet us @APPSPolicyForum or join us on the Facebook group. See acast.com/privacy for privacy and opt-out information.

This week we interview Dr Nigel Hart who has a number of roles including Clinical Senior Lecturer at Queen's University Belfast, Research, Quality Improvement Lead, and of course a General Practitioner. His interest in medical research also led to him climbing Everest!   Hosts: Dr Daniel Butler & Dr Richard Bothwell   Contact:@jollygppodcast   Music: Safety Net by Riot - YouTube Audio Library

Clinical Senior Lecturer in Paediatric Infectious Diseases Dr Jethro Herberg joins Emma Lim and Monica Parker to explore what’s next for sepsis - and what the future of tests and assessment might look like.

Clinical Senior Lecturer in Paediatric Infectious Diseases, Dr Jethro Herberg, joins Emma Lim and Monica Parker to explore what's next for sepsis - and what the future of tests and assessment might look like.  

IWA and Cardiff University debate hosted by Eversheds-Sutherland in Cardiff on 1st May 2019. Claire Sanders, Director of Communications and Marketing, Cardiff University, welcomes delegates to the debate, and is followed by the Chair. Chair: Bethan Lewis, Education & Family correspondent, BBC Cymru Wales introduces panelists and opens debate: Panellists: Theo Davies Lewis, Co-Founder, Darogan Ami Jones, HR Consultant, Aible Dr Frances Gerrard, Clinical Senior Lecturer, Cardiff University School of Medicine Iwan Thomas, CEO, PLANED

This week’s guest, Australian intensivist Dr Ed Litton, truly amazes and inspires me. Despite having a full-time clinical and research career, and a young family, Ed pursues his passion for adventure mostly through ultra-endurance exercise. Many intensivists run, swim, cycle or do other sorts of vigorous exercise in their spare time. Some even run marathons, swim regularly with a squad or cycle long distances to and from work. Some do all 3 by competing in triathlon events. Yet not too many intensivists take on ironman triathlons like Ed does. And how many cycle across Australia from Sydney to Perth as he did a couple of years ago? Ed uses adventure and exercise to keep refreshed for his busy medical career. So to me this podcast conversation is a real treat. Hearing about this massive cross-continent bike ride, the recent family cycling trip across the New Zealand Alps he and his wife did with their 2 young children, and his love for other physical pursuits like surfing and climbing, is both educational and inspiring. Ed Litton is a Staff Specialist in Intensive Care Medicine and Director of ICU Research at Fiona Stanley Hospital in Perth, Australia, and a Clinical Research Fellow in the ICU at St John of God Hospital in Subiaco. He is the recipient of a National Health and Medical Research Council Early Career Fellowship and is a Clinical Senior Lecturer at the University of Western Australia. Ed is a member of the executive committee of the Australia and New Zealand Intensive Care Society Centre for Outcomes Research Evaluation where he is clinical director of the Critical Care Resources Registry. He’s received over $6M in research support and published over 60 manuscripts in the peer reviewed literature. I have admired Ed and his thoughtful approach to intensive care and to life for several years now. Apart from his approach to adventure and exercise he has many valuable perspectives on his bedside approach including: What fascinates him about Intensive Care Some of the things he learnt from his key mentors The importance of reassurance for patients Mixing patient-centred and digital information The 2 phase ward round at his ICU The internal pressure he felt as a new consultant to make fast decisions Creating the right atmosphere in communicating with colleagues His tendency to ruminate about his patients Fatigue during ward rounds His thoughts on sleep How he uses meditation The value of reading books The difficulty in trying to be a jack of all trades in our careers. Ed is caring, mature and very patient-focused. He’s also a super fit athlete. Please enjoy listening to the podcast. Andrew Davies   -------------------- About the Mastering Intensive Care podcast: The podcast is aimed to inspire and empower you to bring your best self to the intensive care unit through conversations with thought-provoking guests. I hope you’ll hear perspectives to help you improve as a healthcare professional and as a human being with the aim of helping your patients receive the best possible care.   -------------------- Links to people, organisations and other resources mentioned: Ed Litton on Twitter: @ed_litton Article about Ed Litton’s bike ride across Australia Alex Psirides Simon Finfer Muse Rottnest Island swim New Normal Project podcast New Normal Project podcast - episode 48 with Caldwell Esselstyn New Normal Project podcast - episode 49 with Scott Stoll Book "In Shock" (by Rana Awdish) Mastering Intensive Care podcast Mastering Intensive Care page on Facebook Mastering Intensive Care at Life In The Fast Lane Andrew Davies on Twitter: @andrewdavies66 Andrew Davies on Instagram: @andrewdavies66 Email Andrew Davies

Julie Howle is a talented triathlete and surgical oncologist. She's currently the Head of the Melanoma and Sarcoma Multidisciplinary Groups at Westmead Hospital here in Sydney and a Clinical Senior Lecturer at The University of Sydney. Julie is also an Age Group World Champion triathlete, having won her AG at the ITU Long Distance World Championships in 2017. And she's a 2x finisher for the Hawaii Ironman in Kona (in 2017 and 2018). Plus she’s someone who openly admits that her experience of changing degrees at University “laid the foundation for a lifetime of the imposter syndrome”. Julie and I discuss: - how being resilient and focusing on her goals has helped her navigate her experience with the Imposter Complex, - how the words “World Champion” sit with her, - why she took almost 10 years from her first triathlon to do her first Ironman, - why being sick in the week leading up to her 1st Hawaii Ironman at Kona was a good thing, - how she’s realised getting stuck in ‘comparison’ ruins her enjoyment of the sport, - sow she (as a melanoma specialist living here in Australia, a country with one of the highest rates of skin cancer) protects her skin from the sun while training and racing, and - what you need to do to protect and monitor your skin. Julie is such a softly spoken, humble and genuinely lovely woman. I hope you enjoy this conversation as much as I did. Get the full show notes for the episode here. — Visit the Sparta Chicks Radio website here https://www.spartachicks.com/radio/ Follow Sparta Chicks Radio on Facebook: facebook.com/SpartaChicks

Hosts: Ed Brown, Penny Dumsday, Mick Vagg 00:02:13 How serious is the opioid crisis in Australia? What's being done about it, and what new painkillers are on the horizon? Pain Specialist Professor Mick Vagg gives us the run down. 00:22:15 20 million years ago, dolphins had really long snouts - the question is why? What evolutionary pressures led to their evolution, and what caused them to become extinct? 00:28:11 Are chimpanzees selfish? Do they readily cooperate? A study on chimpanzees in the Republic of Congo found they often make decisions that benefit others faster than ones that help themselves.   Associate Professor Mick Vagg is Clinical Senior Lecturer at Deakin University School of Medicine, and Pain Specialist at Barwon Health.   This episode contains traces of John Oliver talking shady business practices which have contributed to the US Opioids Crisis.  

Hosts: Ed Brown, Dr. Shayne Joseph, Penny Dumsday, Lucas Randall, Dr. Helen Maynard-Casely, Dr. Mick Vagg 00:03:26 The recent discovery of dunes on Pluto surprised planetary scientists. With very little atmosphere or wind, what could cause them? 00:11:48 A sample from Mars, analysed by the Curiosity rover, has found organic molecules - the building blocks of life. 00:18:25 One of the most famous psychology experiments, the Stanford marshmallow test, looked at delayed gratification in children back in the 1960s and 1970s. It's now been reproduced, a lot more rigorously, and the results are very different. 00:24:32 A proof-of-concept blood test can determine how far a long a woman is in her pregnancy, and how likely she is to give birth ahead of term. 00:28:22 An emerging field of diagnostics, liquid biopsy, is seeing impressive results. Recent studies correctly diagnosed people with ovarian and liver cancers 80 percent of the time. 00:31:51 Planet Nine is an exciting hypothesis that goes part of the way towards explaining the strange orbits of many rocks in the Kuiper Belt. But another idea could answer a lot of the same questions, without the need for a giant undiscovered planet.   Dr. Helen Maynard-Casely is an instrument scientist for the WOMBAT high-intensity powder diffractometer at the Bragg Institute. She writes “The Shores of Titan” column on The Conversation. Dr. Mick Vagg is a rehabilitation and pain medicine specialist, and a Clinical Senior Lecturer at Deakin University. This episode contains traces of dogged CBS Philly reporter Nicole Brewer on a groundbreaking communication study.

On this episode of Sequenced, Dr. Ranjit Manchandra, Clinical Senior Lecturer at Barts Cancer Institute in London, sits down with Business Insider’s Erin Brodwin to discuss population-based genetic testing for cancer prevention. Dr. Manchandra’s recent research found that population testing for multiple breast cancer genes has the potential to be both cost-effective and life-saving.

Deprescribing, a subject that has gained increasing importance in prescribing practice across the world over the last decade is discussed in this European Journal of Hospital Pharmacy's special podcast. The editors of the themed issue, Barry Jubraj, Clinical Senior Lecturer, King’s College London and Nina Barnett, Consultant Pharmacist, Medicines Use and Safety Division, NHS Specialist Pharmacy Service, examine its highlights. Read 'A themed journal issue on deprescribing' here: http://ejhp.bmj.com/content/24/1.toc.

Up to half a million people in the UK could have it, but it's a condition that hardly anybody has heard about: Charles Bonnet Syndrome. It happens to people who are losing their sight through age-related macular degeneration, cataracts, diabetic eye problems or glaucoma. They see vivid and often frightening visual hallucinations and these images are soundless. Judith Potts' mother Esme was in her 90's when she eventually admitted to her daughter that she was seeing frightening images of goblins and Victorian children all around her. Judith had never heard of the condition and as she tells Dr Mark Porter, neither had any of the health professionals taking care of her mother. Shocked that there was so little awareness about something that is so common, she set up an awareness group, Esme's Umbrella. Dr Dominic Ffytche, Clinical Senior Lecturer at King's College London's Institute of Psychiatry and an expert in visual hallucinations, tells Mark that a key area of research is why some people have Charles Bonnet Syndrome and others don't. Co-proxamol, or Distalgesic as it's better known, was a common drug for mild to moderate pain in the 1990's. But a decade ago, a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) decided that it wasn't a good painkiller and it had very worrying side effects. Its licence was withdrawn and doctors were urged to switch patients onto different medication (although it could still be prescribed on a "named patient" basis). Dr Andrew Green, Chair of the Clinical and Prescribing arm of the GP committee of the British Medical Association tells Mark he's disturbed that nearly ten years after the licence was withdrawn, thousands of patients are still being prescribed co-proxamol at a high cost to the NHS while Bedfordshire GP Dr John Lockley defends continued and careful prescribing for a tiny number of patients who can't get relief from other medication. In a week in which hundreds of thousands of people have signed a petition calling for more children to receive the Meningitis B vaccine, Dr Margaret McCartney talks to Mark about the tricky decisions involved in planning immunisation programmes. Traditional bedside paper charts, which record and monitor patients' vital signs, have been replaced in Oxford hospitals with smart PC tablets. Clinical staff enter patients' blood pressure, heart rate and temperature on the tablet and the new "smart" system provides an early warning traffic light system, alerting them if there's a deterioration in the patient's condition. This means clinicians can prioritise care and another major bonus is that the same information is available, at the touch of a button, to medical staff across Oxford's hospitals. The project is called SEND - System for Electronic Notification and Documentation - and it's a collaboration between the University of Oxford and Oxford University Hospitals NHS Foundation Trust. Mark goes to Oxford and with intensive care consultant and SEND Project Leader Dr Peter Watkinson, sees how the new paperless system is working.

Dr Richard Chin, Clinical Senior Lecturer and Director of the Muir Maxwell Epilepsy Centre (MMEC) at the University of Edinburgh, delivers the second lecture in the 2014 Medical Detectives series, entitled "Unlocking the Mysteries of Childhood Epilepsy". This talk addresses some of the major challenges in childhood epilepsy: identifying the cause, finding better treatments, and dealing with the learning and behavioural problems in epilepsy. http://www.ed.ac.uk/news/events/medical-detectives/2014/chin Recorded on 9 October 2014 at the University of Edinburgh's Anatomy Lecture Theatre.

Introduction by Professor Patrick Maxwell, Dean, UCL Faculty of Medical Sciences. Hugh Montgomery, Professor of Intensive Care Medicine (Honorary Consultant), UCL Division of Medicine, "Serving an ACE!" Ken van Someren, Director of Sport Sciences, English Institute of Sport, "The elite athlete – extremes of exercise and performance". Ian Roberts, Professor of Epidemiology & Public Health, London School of Hygiene & Tropical Medicine,"They paved paradise and put up a parking lot". Panel discussion (with speakers above and those listed below): Vincent Walsh, Professor of Human Brain Research, UCL Institute of Cognitive Neuroscience, Jenny Mindell, Clinical Senior Lecturer, UCL Institute of Epidemiology & Health Care

Introduction by Professor Patrick Maxwell, Dean, UCL Faculty of Medical Sciences. Hugh Montgomery, Professor of Intensive Care Medicine (Honorary Consultant), UCL Division of Medicine, "Serving an ACE!" Ken van Someren, Director of Sport Sciences, English Institute of Sport, "The elite athlete – extremes of exercise and performance". Ian Roberts, Professor of Epidemiology & Public Health, London School of Hygiene & Tropical Medicine,"They paved paradise and put up a parking lot". Panel discussion (with speakers above and those listed below): Vincent Walsh, Professor of Human Brain Research, UCL Institute of Cognitive Neuroscience, Jenny Mindell, Clinical Senior Lecturer, UCL Institute of Epidemiology & Health Care